Patient-derived glioblastoma organoids reflect tumor heterogeneity and treatment sensitivity.
Saved in:
| Title: | Patient-derived glioblastoma organoids reflect tumor heterogeneity and treatment sensitivity. |
|---|---|
| Authors: | Verduin M; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands., Hoosemans L; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands., Vanmechelen M; Laboratory for Precision Cancer Medicine, Translational Cell and Tissue Research Unit, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.; LISCO-KU Leuven Institute for Single Cell Omics, KU Leuven, Leuven, Belgium., van Heumen M; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands., Piepers JAF; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands., Astuti G; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Ackermans L; Department of Neurosurgery, School for Mental Health and Neuroscience (MHeNS), Maastricht University Medical Center, Maastricht, The Netherlands., Schijns OEMG; Department of Neurosurgery, School for Mental Health and Neuroscience (MHeNS), Maastricht University Medical Center, Maastricht, The Netherlands.; Academic Center for Epileptology, Maastricht University Medical Center and Kempenhaeghe, Maastricht-Heeze, The Netherlands., Kampen KR; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands.; Laboratory for Disease Mechanisms in Cancer, Department of Oncology, KU Leuven, Leuven, Belgium., Tjan-Heijnen VCG; Department of Medical Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands., de Barbanson BA; Barbanson Biotech., Postma AA; Department of Radiology and Nuclear Medicine, School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands., Eekers DBP; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands., Broen MPG; Department of Neurology, Maastricht University Medical Center, Maastricht, The Netherlands., Beckervordersandforth J; Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands., Staňková K; Institute for Health Systems Science, Delft University of Technology, Delft, The Netherlands., de Smet F; Laboratory for Precision Cancer Medicine, Translational Cell and Tissue Research Unit, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.; LISCO-KU Leuven Institute for Single Cell Omics, KU Leuven, Leuven, Belgium., Rich J; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Hubert CG; Department of Biochemistry, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA., Gimenez G; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand., Chatterjee A; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand., Hoeben A; Department of Medical Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands., Vooijs MA; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands. |
| Source: | Neuro-oncology advances [Neurooncol Adv] 2023 Nov 25; Vol. 5 (1), pp. vdad152. Date of Electronic Publication: 2023 Nov 25 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2632-2498 |
|---|---|
| DOI: | 10.1093/noajnl/vdad152 |
